{
    "organizations": [],
    "uuid": "34dfdf467eddccd97d66b3a5461c93962e7c403d",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-collegium-reports-q1-loss-per-shar/brief-collegium-reports-q1-loss-per-share-0-57-idUSASC0A12B",
    "ord_in_thread": 0,
    "title": "BRIEF-Collegium Reports Q1 Loss Per Share $0.57",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 9 (Reuters) - Collegium Pharmaceutical Inc:\n* COLLEGIUM REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE\n* Q1 LOSS PER SHARE $0.57 * Q1 REVENUE $63.7 MILLION VERSUS I/B/E/S VIEW $59.8 MILLION\n* Q1 EARNINGS PER SHARE VIEW $-0.49 â€” THOMSON REUTERS I/B/E/S\n* COLLEGIUM - BELIEVE EXISTING CASH RESOURCES, WITH EXPECTED CASH INFLOWS TO FUND OPERATING EXPENSES, DEBT SERVICE, CAPEX NEEDS AT LEAST INTO 2020 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-10T04:32:00.000+03:00",
    "crawled": "2018-05-10T17:41:44.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "collegium",
        "pharmaceutical",
        "inc",
        "collegium",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "provides",
        "corporate",
        "update",
        "q1",
        "loss",
        "per",
        "share",
        "q1",
        "revenue",
        "million",
        "versus",
        "view",
        "million",
        "q1",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "collegium",
        "believe",
        "existing",
        "cash",
        "resource",
        "expected",
        "cash",
        "inflow",
        "fund",
        "operating",
        "expense",
        "debt",
        "service",
        "capex",
        "need",
        "least",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}